Cargando…
Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
INTRODUCTION: NMDA-Receptor antagonists have rapid antidepressant and antisuicidal properties. However, the antidepressant effect is short lasting raising the question of best maintenance strategy, which is unanswered so far. Invasive vagus nerve stimulation (VNS) as a treatment option for refractor...
Autores principales: | Kavakbasi, E., Baune, B. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596170/ http://dx.doi.org/10.1192/j.eurpsy.2023.572 |
Ejemplares similares
-
Impact of invasive VNS on depression severity and the need of concomitant drug and neuromodulatory treatment dose
por: Kavakbasi, E., et al.
Publicado: (2022) -
Efficacy and safety of intermittent theta burst stimulation (iTBS) in treatment resistant depression
por: Kavakbasi, E., et al.
Publicado: (2022) -
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
por: Marcatili, Matteo, et al.
Publicado: (2022) -
S-Ketamine in the treatment of depressive emergencies: a cases series of patients in a suicidal crisis
por: Baune, B., et al.
Publicado: (2022) -
The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)